Related Experiment Videos
Molecular prognostic factor in renal cell carcinoma
T Shimazui1, E Oosterwijk, F M Debruyne
1Urological Research Laboratory, University Hospital Nijmegen, The Netherlands.
Seminars in Urologic Oncology
|November 1, 1996
Summary
Prognostic factors for renal cell carcinoma (RCC) are needed. Quantitative nuclear morphometry and cadherin-mediated adhesion complexes show promise for predicting RCC progression beyond current clinical staging methods.
Area of Science:
- Oncology
- Pathology
- Molecular Biology
Background:
- Renal cell carcinoma (RCC) exhibits an unpredictable clinical course, necessitating improved prognostic factors.
- Current clinical staging is the primary predictor of RCC progression.
- A deeper understanding of the cell biology and molecular alterations in RCC is crucial.
Purpose of the Study:
- To identify novel prognostic factors for renal cell carcinoma.
- To evaluate the prognostic value of quantitative nuclear morphometry and cadherin-mediated adhesion complexes in RCC.
Main Methods:
- Quantitative nuclear morphometric measurements were performed.
- Immunohistochemistry was used to assess cadherin-mediated adhesion complexes (catenin).
Main Results:
- Some novel markers showed limited prognostic value compared to established markers.
- Quantitative nuclear morphometry and cadherin assessment demonstrated potential as new prognostic indicators for RCC.
Conclusions:
- Quantitative nuclear morphometry and cadherin immunohistochemistry offer new prospects for predicting renal cell carcinoma progression.
- These methods may enhance prognostic accuracy beyond current clinical staging.